Back to US BANCORP \DE\ US BANCORP \DE\

AUPHAUPH

Showing 8 of 30 quarters

Position history for US BANCORP \DE\US BANCORP \DE\'s holdings in AURINIA PHARMACEUTICALS INC

Yes. US Bancorp holds 12,035 shares of AUPH (Aurinia Pharmaceuticals), worth $204,234, as of its Q2 2026 13F filing. It increased the position by 31 shares (+0.3%) from Q1 2026. US Bancorp has held AUPH in every 13F on record since Q1 2019, 30 quarterly filings.

Current Value

$204,234

Current Shares

12,035

Total Value Change

+$116,567

Total Shares Change

+75

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
12,035
+0.3%
$204,2340.0%$16.97
23
2026-Q1
Increased
12,004
+0.4%
$177,8990.0%$14.15
23
2025-Q4
Unchanged
11,960
0.0%
$190,7620.0%$15.82
0
2025-Q3
Decreased
11,960
-0.3%
$132,1580.0%$11.06
0
2025-Q2
Increased
12,001
+0.2%
$101,6480.0%$8.64
22
2025-Q1
Decreased
11,982
-38.1%
$96,3350.0%$8.29
0
2024-Q4
Increased
19,366
+61.9%
$173,9070.0%$9.17
33
2024-Q3
Increased
11,960
+3.3%
$87,6670.0%$7.28
22

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used